Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Hendricks

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapyM M Bartik, M C Ahn, B A Baumgartel, et al.
The Journal of General Virology|July 1, 1991
Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal diseaseR L Hendricks, P C Weber, J L Taylor, et al.
Progress in Retinal and Eye Research|September 5, 2012
Herpes keratitisA M Rowe, A J St Leger, S Jeon, et al.
Journal of Virology|February 1, 1994
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cellsK S Dingwell, C R Brunetti, R L Hendricks, et al.
Ophthalmology|October 1, 1989
Herpes simplex keratitis in patients with acquired immune deficiency syndromeT L Young, J B Robin, G N Holland, et al.
Journal of Virology|April 1, 1994
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeatsW F Goins, L R Sternberg, K D Croen, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapyM M Bartik, M C Ahn, B A Baumgartel, et al.
The Journal of General Virology|July 1, 1991
Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal diseaseR L Hendricks, P C Weber, J L Taylor, et al.
Progress in Retinal and Eye Research|September 5, 2012
Herpes keratitisA M Rowe, A J St Leger, S Jeon, et al.
Journal of Virology|February 1, 1994
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cellsK S Dingwell, C R Brunetti, R L Hendricks, et al.
Ophthalmology|October 1, 1989
Herpes simplex keratitis in patients with acquired immune deficiency syndromeT L Young, J B Robin, G N Holland, et al.
Journal of Virology|April 1, 1994
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeatsW F Goins, L R Sternberg, K D Croen, et al.
Pageof 5